Showing 2351-2360 of 5347 results for "".
Get Ready for JAK Inhibitors
https://practicaldermatology.com/topics/psoriasis/get-ready-for-jak-inhibitors/19928/JAK inhibitors are going to change the way we think about refractory disease, says Brett King, MD. He addresses the significant increase in study of these agents and the many potential uses for refractory diseases like alopecia, atopic dermatitis, vitiligo, psoriasis, and more.Acne Update: A Review of New Guidelines, Treatment Advances, and Drugs in the Pipeline
https://practicaldermatology.com/topics/general-topics/acne-update-a-review-of-new-guidelines-treatment-advances-and-drugs-in-the-pipeline/18773/Linda Stein Gold, MD talks to DermTube Journal Club Host Joshua Zeichner, MD about the new acne treatment guidelines recently published in the Journal of the American Academy of Dermatology. She discusses the process of developing the guidelines and highlights some of what's new, such as new, limiteGold's Standards: Nashville's Laser Guru on Best Practices
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/gold-s-standards-nashville-s-laser-guru-on-best-practices/18867/When a third of your practice is dedicated to energy-based devices, it's important to find the best solutions for your patient flow. In this edition of Best Practices, Joel L. Cohen, MD talks to Michael H. Gold, MD about his approach to adoption and promotion of energy-based devices. Dr. Gold discusMaui Derm Panel: GLP-1 Agonists Can Help Psoriasis Patients
https://practicaldermatology.com/programs/practical-dermatology/maui-derm-panel-glp-1-agonists-can-help-psoriasis-patients/32917/Only 11% of Maui Derm 2025 audience members polled said they were comfortable prescribing weight-loss drugs, and 49% said they were not at all—but they should be, according to the presenters of “Psoriasis Update 2025” at the conference in Maui, Hawaii.Close Up With Gil Yosipovitch, MD
https://practicaldermatology.com/columns/physician-spotlight/close-up-with-gil-yosipovitch-md/24002/Next Generation Environmental Protection: Antioxidants and Chelators
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/next-generation-environmental-protection-antioxidants-and-chelators/23802/As understanding of the pathogenesis of skin aging and carcinogenesis evolves, so do topical protective strategies.A Practical Guide to Modern Melasma Treatment
https://practicaldermatology.com/topics/pigmentary-disorders/a-practical-guide-to-modern-melasma-treatment/67256/Modern management of melasma requires an individualized approach with targeted therapies that incorporate updated knowledge of disease pathogenesis.Next-Generation TYK2 Inhibitors in Psoriasis
https://practicaldermatology.com/topics/psoriasis/next-generation-tyk2-inhibitors-in-psoriasis/60985/Phase 3 clinical data and emerging therapeutic implications demonstrate the promise of zasocitinib and envudeucitinib.Encouraging Conversation
https://practicaldermatology.com/topics/skin-cancer-photoprotection/encouraging-conversation-40-gep-testing-for-adjuvant-radiation-therapy-candidates/37104/Two studies validate the 40-GEP test for identifying patients most likely to benefit from adjuvant radiation therapyStaphylococcus aureus Accessory Gene Regulator Quorum-sensing System Inhibits Keratinocyte Lipid Enzymes and Delays Wound Repair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/staphylococcus-aureus-accessory-gene-regulator-quorum-sensing-system-inhibits-keratinocyte-lipid-enzymes-and-delays-wound-repair/67354/Therapies aimed at inhibiting agr quorum sensing could be a novel strategy to improve healing outcomes.